[The state of the art of gastric antisecretory drugs]
- PMID: 8406234
- DOI: 10.1254/fpj.102.235
[The state of the art of gastric antisecretory drugs]
Abstract
This review article describes the effect and mechanism of various antisecretory drugs. Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases. Because of their potential effectiveness in inhibiting gastric acid secretion, new H2-antagonists and pump inhibitors are under development with the aim of mitigating of the side effects. The local antisecretory effects of FPL-52694, NC-1300-O-3 and ME 3407, which were demonstrated in Heidenhain pouch dogs, will provide clues for the development of new types of antisecretory drugs. Antigastrin drugs are also promising.
Similar articles
-
Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.Eur J Pharmacol. 1993 Apr 28;235(2-3):245-53. doi: 10.1016/0014-2999(93)90143-6. Eur J Pharmacol. 1993. PMID: 8099553
-
Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.Eur J Pharmacol. 1983 Aug 5;91(4):371-6. doi: 10.1016/0014-2999(83)90160-7. Eur J Pharmacol. 1983. PMID: 6137398
-
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.Jpn J Pharmacol. 1991 Apr;55(4):425-36. doi: 10.1254/jjp.55.425. Jpn J Pharmacol. 1991. PMID: 1886288
-
Control of gastric secretion.Proc Nutr Soc. 1996 Mar;55(1B):251-8. doi: 10.1079/pns19960026. Proc Nutr Soc. 1996. PMID: 8832797 Review. No abstract available.
-
[Gastrin/CCK-B receptor antagonists for a novel antiulcer agent].Nihon Yakurigaku Zasshi. 1995 Sep;106(3):171-80. doi: 10.1254/fpj.106.171. Nihon Yakurigaku Zasshi. 1995. PMID: 8529962 Review. Japanese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources